THIS CONVERTIBLE DEBENTURE PURCHASE AGREEMENT (the "Agreement" ) is made as of February 14 , 2008, by and between Vycor Medical, Inc., a Delaware corporation (the " Company ") and Regent Private Capital, LLC, an Oklahoma limited liability company ( "Regent ").
Convertible Debenture Purchase Agreement • December 6th, 2001 • Composite Industries of America Inc • Operative builders • New York
Contract Type December 6th, 2001 JurisdictionConvertible Debenture Purchase Agreement • March 19th, 1998 • Eurotech LTD • Hazardous waste management
Contract Type March 19th, 1998Convertible Debenture Purchase Agreement • June 17th, 1998 • Eurotech LTD • Hazardous waste management • New York
Contract Type June 17th, 1998 JurisdictionConvertible Debenture Purchase Agreement • May 23rd, 2000 • Forest Glade International Inc • Operators of nonresidential buildings • New York
Contract Type May 23rd, 2000 JurisdictionConvertible Debenture Purchase Agreement • February 10th, 2004 • Advanced Id Corp • Semiconductors & related devices
Contract Type February 10th, 2004Convertible Debenture Purchase Agreement • June 4th, 1998 • Fix Corp International Inc • Plastic materials, synth resins & nonvulcan elastomers
Contract Type June 4th, 1998Convertible Debenture Purchase Agreement • September 24th, 1999 • Sonic Foundry Inc • Services-prepackaged software • New York
Contract Type September 24th, 1999 Jurisdiction Convertible Debenture Purchase Agreement • April 2nd, 2021 • North Carolina Contract Type April 2nd, 2021 JurisdictionTHIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT THIS INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET EXISTS FOR THE SECURITIES, AND NO PUBLIC MARKET IS EXPECTED TO DEVELOP FOLLOWING THIS OFFERING.
Convertible Debenture Purchase Agreement • April 21st, 2000 • Neotherapeutics Inc • Services-commercial physical & biological research • New York